Opioid detox for Palm Beach Gardens — fentanyl-era protocols, buprenorphine done right.

For Palm Beach Gardens residents in PGA National, Mirasol, BallenIsles, Frenchman's Reserve, or Old Palm, RECO Island's Delray Beach campus is a 35-minute drive south on I-95. Opioid detox is COWS-guided, buprenorphine-forward, and structured for the fentanyl era, with 24/7 nursing, physician management, and direct in-house transition to residential care. No waitlists, no third-party handoffs, and naloxone education plus a take-home prescription at discharge as standard-of-care.

Palm Beach Gardens sits 25 miles north of Delray Beach — about 35 minutes south on I-95 in typical traffic. For residents of PGA National, Mirasol, BallenIsles, Frenchman’s Reserve, and Old Palm, that short drive opens access to physician-managed medical detox with 24/7 nursing and a direct in-house transition to residential care that outpatient practices in northern Palm Beach County generally do not deliver. Opioid detox at RECO Island is COWS-guided, buprenorphine-forward, and staffed for the fentanyl era — where street opioid potency and unpredictable adulterants have materially changed withdrawal management.

Opioid withdrawal in the fentanyl era

Fentanyl and its analogs have rewritten opioid withdrawal management. Compared with heroin or prescription oxycodone, fentanyl’s high potency and unpredictable pharmacokinetics produce withdrawal that emerges faster, hits harder, and is less predictable — particularly in patients who have been using pressed pills of unknown composition. Adulterants including xylazine, benzodiazepine analogs, and novel synthetic opioids further complicate the clinical picture, and the traditional 12-24 hour COWS window for buprenorphine induction is no longer a reliable rule of thumb.

Admission at RECO Island begins with a full medical assessment, urine toxicology, and structured withdrawal scoring. Patients with recent fentanyl exposure are risk-stratified for precipitated withdrawal, and induction timing is adjusted accordingly. Where warranted, low-dose or micro-induction protocols — beginning at 0.5-1 mg buprenorphine and titrating upward over several days alongside a longer-acting comfort medication regimen — reduce the risk of the acute, iatrogenic withdrawal that has become a significant deterrent to MAT initiation in fentanyl-exposed patients.

COWS-guided buprenorphine induction

The Clinical Opiate Withdrawal Scale (COWS) is the workhorse assessment for timing buprenorphine induction. It scores eleven symptom domains — resting pulse, sweating, restlessness, pupil size, bone and joint aches, rhinorrhea or lacrimation, GI upset, tremor, yawning, anxiety or irritability, and gooseflesh skin — and yields a total that categorizes withdrawal as mild, moderate, moderately severe, or severe.

Standard induction begins when COWS crosses the moderate threshold, historically around 11 or higher, with an initial dose of 2-4 mg sublingual buprenorphine and titration over the first 24 hours to a clinically effective range of 8-16 mg daily. Comfort medications supplement the induction: clonidine for autonomic hyperactivity, loperamide for GI symptoms, ondansetron for nausea, methocarbamol or cyclobenzaprine for muscle spasm, and hydroxyzine or trazodone for insomnia. IV fluids and electrolyte correction are used where clinically indicated. Nursing documents COWS scores at scheduled intervals, and physicians adjust the plan in real time.

Buprenorphine, methadone, or naltrexone — the MAT decision

Medication for opioid use disorder (MOUD) after detox is not a single choice. Three medications have strong evidence for reducing return-to-use and overdose mortality: buprenorphine, a partial mu-agonist with a ceiling effect that limits overdose risk and can be prescribed in office-based settings; methadone, a full agonist dispensed through federally regulated opioid treatment programs; and extended-release naltrexone, a monthly intramuscular opioid antagonist that requires a 7-10 day opioid-free interval before initiation to avoid precipitated withdrawal.

The decision is made collaboratively during the detox stay. Buprenorphine (Suboxone, Sublocade) is often the default for patients who tolerate induction and prefer an office-based maintenance model. Methadone is considered for patients with long-standing high-tolerance use, prior failed buprenorphine trials, or clinical instability. Extended-release naltrexone (Vivitrol) is appropriate for patients who have completed a full washout, are motivated by an antagonist strategy, and have a support structure that accommodates monthly injection appointments. Prior response, employment considerations, and outpatient access at discharge all inform the choice.

Naloxone education and the safety net

Every patient completing opioid detox at RECO Island — and, where possible, a family member — receives naloxone education and a take-home prescription. This is standard-of-care, not optional programming. The 30-90 day window after detox carries the highest overdose mortality risk in a patient’s trajectory: opioid tolerance has dropped substantially while return-to-use risk remains real, and a dose that was manageable a week earlier can be lethal after even a brief abstinence.

Education covers recognition of overdose (unresponsiveness, slow or absent breathing, cyanosis), correct administration of intranasal naloxone (Narcan or Kloxxado), rescue breathing, and the importance of calling 911 even after successful reversal because naloxone’s duration is shorter than fentanyl’s. Families are briefed on Florida’s Good Samaritan law. MAT continuation, naloxone availability, and clear aftercare instructions are the three interventions that consistently move the post-detox mortality curve.

What to expect on your first day

Admission begins with a nursing intake and a physician evaluation, typically within the first hour of arrival. Vitals, medication reconciliation, urine toxicology, comprehensive metabolic panel, CBC, hepatitis and HIV screening, and pregnancy testing where applicable are completed on day one. Structured assessments include COWS for opioid withdrawal, CIWA-Ar if concurrent alcohol or benzodiazepine use is present, PHQ-9 for depression, GAD-7 for anxiety, and the ASAM Criteria six-dimension evaluation that drives the level-of-care recommendation.

The clinical team meets that afternoon or evening to finalize the detox protocol, comfort medication orders, and provisional MAT plan. Individual counseling with a masters-level therapist begins on day two once withdrawal is medically stabilized, using motivational interviewing (MI) and cognitive-behavioral (CBT) frameworks. For patients transitioning into residential care, the residential clinical team is looped in early so there is no gap — no reassessment appointment, no waitlist, no third-party handoff.

Insurance and admissions from Palm Beach Gardens

RECO Island is in-network or accepts benefits with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and Blue Cross Blue Shield plans. Verification of benefits is typically completed within a few business hours, and admissions runs seven days a week. For Palm Beach Gardens residents, the geography works in your favor: a single 35-minute drive south places you inside a fully integrated detox-to-residential program, and a family member can complete the drive from Frenchman’s Reserve or PGA National, drop off a patient, and be home the same afternoon.

Admissions coordinators will confirm coverage, out-of-pocket exposure, and — for patients considering extended-release naltrexone as a discharge plan — the specific Vivitrol prior authorization requirements of your plan, since these vary. Same-day admission from the northern Palm Beach County corridor is routine when clinical criteria are met and benefits verify cleanly.

Serving residents of: BallenIsles, Frenchman's Reserve, Mirasol, Old Palm, PGA National.